EMERGENCY: Coronavirus disease (COVID-19) Pandemic16/03/2020
Regular updates on the coronavirus disease (COVID-19) outbreak are available at the WHO website.
Launch of online learning programme on “Improving the Quality of Cancer Screening”08/02/2021
We are pleased to announce the launch of a new freely accessible and modular resource on cancer screening and early diagnosis. This self-paced online learning programme was developed in the framework of the Cancer Screening in Five Continents (CanScreen5) project. This course was developed with the support of the American Cancer Society, the Medical Research Council (United Kingdom), the Research Council of Norway, and the Centre for Global Health Inequalities Research (CHAIN) of Norway. This open access learning programme covers evidence-based knowledge and skills on “Improving the Quality of Cancer Screening” through a variety of educational resources through 3 modules: principles of cancer screening, planning and implementing a cancer screening programme, and quality of cancer screening programmes.
View the IARC news and join the learning programme
Virtual meeting: Europe’s path to eliminating cervical cancer on 5 February at 14:00 CET time05/02/2021
Cervical cancer is a significant health problem in Europe. WHO Member States have collectively resolved to end needless suffering from a cancer that is preventable, curable and could be eliminated within a generation by adopting the global strategy to accelerate the elimination of cervical cancer as a public health problem in November 2020. The objective of this webinar organized by the Associations of the European Cancer Leagues in collaboration with UICC, MEP, European Commission DG Santé and IARC is to inform a wide audience of health stakeholders about the global strategy and discuss Europe’s role in taking global commitments forward and signalling the importance of cervical health to European Member States, Associated countries and beyond. View the agenda and join the meeting
New publication: Cross-sectional survey of the impact of the COVID-19 pandemic on cancer screening programmes in selected low- and middle-income countries: study from the IARC COVID-19 impact study group04/02/2021
In this new article, published in the International Journal of Cancer, the IARC COVID-19 impact study group including scientists from IARC and representatives from 17 countries in charge of cancer screening programmes, conducted a study to assess the impact of the pandemic on cancer screening programmes in LMICs that have made significant efforts in the past few years to improve the organization of their screening programmes. Based on our best knowledge, our study is the first reporting on the impact of COVID-19 outbreak on cancer screening care continuum for a set of low- and middle-income countries spread across different continents and Human development index categories. The status of the cancer testing, diagnostic and treatment services, and challenges and the best practices adopted to face the crisis are described. Sharing such information will help LMICs to improve resilience of screening services. View the article
New commentary: Eliminating cervical cancer in the COVID-19 era04/02/2021
The COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus, poses a clear and present danger to the health and well-being of populations. A new comment, published in Nature Cancer by Dr Ophira Ginsburg, Dr Partha Basu, Dr Sharon Kapambwe and Dr Karen Canfell, discuss its indirect impact on global cancer prevention and control efforts, particularly for cervical cancer. Authors suggest some comparisons between the COVID-19 pandemic and the human papillomavirus–induced cancer burden, as well as opportunities for translating pandemic-control strategies into effective cancer control. View the commentary
New publication: Role of integrative medicine in the continuum of care of breast cancer patients in the Indian context03/02/2021
In the present review article published in Cancer Causes Control, the authors discussed the possible role of integrative medicine across the breast cancer care continuum with the concept of integrating complementary practices into mainstream health delivery. Authors have focused on breast cancer as a model cancer that is well amenable to prevention, early detection and stage appropriate treatment. However, their observations are pertinent for other common cancers, for which there are several opportunities for improving the continuum of care, especially in developing countries like India.View the article
Digital atlas of visual inspection of the cervix with acetic acid for screening, triage, and assessment for treatment02/02/2021
IARC SUMMER SCHOOL 2021 – 100% ONLINE – APPLY NOW!01/02/2021
IARC Summer School 2021 applications are now open! Courses will be held fully online this year, offering a unique opportunity to learn and benefit from IARC’s expertise from anywhere in the world! Two modules will be offered this year: “Introduction to Cancer Epidemiology” and “Implementing Cancer Prevention and Early Detection”. Application deadline: 1 March.
CanScreen5 Train the Trainers - Africa Region Live session 629/01/2021
Continuation of the CanScreen5 Train the Trainers African course, with participants from 17 African countries. The CanScreen5 Train the Trainers course aims to contribute to the creation of a dynamic global network of master trainers capable of training health care providers on cancer screening program monitoring, evaluation and quality improvement and also to contribute data to the CanScreen5 project. Today, Dr P. Basu, deputy head, Early Detection, Prevention and Infections (EPR) Branch, addressed a key not lecture about Cancer screening during and after the COVID-19 pandemic. Learn more about the CanScreen5 platform.
The burden of cancer is rising worldwide. The International Agency for Research on Cancer / World Health Organization (IARC) is focused on cancer research for cancer prevention and promoting international scientific collaborations. Soon, IARC will move to their new HQ, which is currently under construction in the Biodistrict in Gerland, Lyon, France. To continue their important work, they need to buy or receive equipment to outfit the new labs and offices. That’s why they have launched an in-kind contribution campaign and are open to donations, large and small, from individuals and institutions. 7 million lives could be saved from cancer in the next decade alone with the correct prevention strategies. IARC produces the evidence needed to support these strategies and prove that they work. Please support IARC’s research and their move to the new HQ. Supporting IARC is helping contribute to a world with less cancer, especially in low- and middle-income countries where cancer is increasing the most. Learn more about the Nouveau Centre and how to join the circle of IARC donors.